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Abstract 
Background: Treatment alternatives for DHA-1 harboring strains are challenging as it confers resistance to broad spectrum 
cephalosporins and may further limit treatment option when expressed at higher levels. Therefore, this study was designed 
to know the prevalence of DHA genes and analyse the transcription level of DHA-1 against different β-lactam stress.
Methods: Screening of AmpC β-lactamase phenotypically by modified three dimensional extract method followed 
by Antimicrobial Susceptibility and MIC determination. Genotyping screening of β-lactamase genes was performed 
by PCR assay followed by their sequencing. The blaDHA-1 transcriptional response was evaluated under different 
cephalosporin stress by RT PCR. Transferability of blaDHA gene was performed by transformation and conjugation and 
plasmid incompatibility typing, DNA fingerprinting by enterobacterial repetitive intergenic consensus sequences PCR.
Results: 16 DHA-1 genes were screened positive from 176 Escherichia coli isolates and primer extension analysis 
showed a significant increase in DHA-1 mRNA transcription in response to cefotaxime at 8 µg/ml (6.99 × 102 fold), 
ceftriaxone at 2 µg/ml (2.63 × 103 fold), ceftazidime at 8 µg/ml (7.06 × 103 fold) and cefoxitin at 4 µg/ml (3.60 × 104 
fold) when compared with untreated strain. These transcription data were found significant when analyzed statisti-
cally using one way ANOVA. Four different ESBL genes were detected in 10 isolates which include CTX-M (n = 6), 
SHV (n = 4), TEM (n = 3) and OXA-10 (n = 1), whereas, carbapenemase gene (NDM) was detected only in one isolate. 
Other plasmid mediated AmpC β-lactamases CIT (n = 9), EBC (n = 2) were detected in nine isolates. All DHA-1 genes 
detected were encoded in plasmid and incompatibility typing from the transformants indicated that the plasmid 
encoding blaDHA-1 was carried mostly by the FIA and L/M Inc group.
Conclusion: This study demonstrates the prevalence of DHA-1 gene in this region and highlights high transcription 
of DHA-1 when induced with different β-lactam antibiotics. Therefore, cephalosporin treatment must be restricted for 
the patients infected with pathogen expressing this resistance determinant.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Escherichia coli (E. coli) possess a chromosomal cephalo-
sporinase gene, which is regulated by a weak promoter and 
a transcriptional attenuator. The gene confers resistance 
only to narrow-spectrum cephalosporins [1, 2]. However, 
spontaneous mutations in the promoter, as well as tran-
scriptional attenuator region of the AmpC gene may induce 
constitutive overproduction of the cephalosporinase 
resulting in resistance to penicillins and broad-spectrum 
cephalosporins (e.g. cefotaxime, ceftazidime, ceftriaxone, 
aztreonam etc.) [3, 4]. Besides hyper-production of the 
chromosomally encoded enzyme, the presence of one or 
more plasmid-mediated AmpC β-lactamases along with 
other intrinsic mechanisms in E. coli leads to resistance 
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against multiple antimicrobial agents, compromising the 
efficacy of treatment [5–7]. Six families of plasmid-encoded 
AmpC β-lactamases were described based on their 
sequence similarities as CIT, FOX, MOX, DHA, EBC, and 
ACC [8]. The most commonly recognized plasmid-medi-
ated AmpC among the strains of E. coli includes the CMY-2 
type which belongs to the CIT family [9, 10].
DHA-1, another plasmid-mediated AmpC β-lactamase, 
belonging to DHA family was found increasingly among 
Enterobacteriaceae in many parts of the world and was a 
growing concerned in the medical world as it leads to treat-
ment failure [7]. It was first characterized in a Salmonella 
enteritidis which has the ability to hydrolyze penicillins, 
cephamycin, including broad spectrum cephalosporin leav-
ing physicians with limited antibiotic choices. It was also 
the first plasmid-encoded β-lactamase found to be induc-
ible and can be expressed in high levels [11, 12]. So far a 
total of 24 gene types of DHA family have been reported 
(http://www.ncbi.nlm.nih.gov/projects/pathogens/submit_
beta_lactamase). The regulation of this β-lactamase expres-
sion is closely linked to cell wall recycling and involves at 
least three genes: ampR (codes for a transcriptional regula-
tor of the LysR family), ampG (codes for a transmembrane 
permease) and ampD (codes for a cytosolic N-acetyl-anhy-
dromuramyl- l-alanine amidase) [13].
Though it was well established that β-lactam antibiot-
ics are potent inducers of class C in most of the members 
of the family Enterobacteriaceae [7], there is no relevant 
information on the level of AmpC expression taking place 
when the strains with incomplete regulatory elements 
were under antibiotic stress. Therefore, this study was 
undertaken to investigate the transcriptional response of 
DHA-1 under various cephalosporin’s stresses.
Methods
Bacterial strains
A total of 176 consecutive, non-duplicate Escherichia 
isolates were collected from different clinical speci-
mens (mostly from urine followed by pus) obtained 
from different Wards/OPD of Silchar Medical College 
and Hospital, India from October 2012 to March 2013. 
The isolates were identified by cultural characteris-
tics, biochemical reactions and further confirmed by 
16S rDNA sequencing using primers, a forward primer 
5′-AGAGTTTGATCMTGGCTCAG-3′ and a reverse 
primer 5′-TACGGYTACCTTGTTACGACTT-3′.
Screening of AmpC β‑lactamase by cefoxitin disc test 
and modified three dimensional extract method
Preliminary screening of AmpC β-lactamase was carried 
out on Mueller–Hinton Agar plates containing cefoxi-
tin (30 µg) (Hi Media, Mumbai). Isolates with inhibition 
zones of less than 18  mm, were considered as screen 
positives [14]. The suspected AmpC β-lactamase pro-
ducers were further confirmed by modified three dimen-
sional extract test (M3DET) [15]. Escherichia coli ATCC 
25922 and Enterobacter cloacae P99 were used as nega-
tive and positive control respectively.
Antimicrobial susceptibility and minimum inhibitory 
concentrations (MIC’s) determination
Antimicrobial susceptibility was determined by Kirby 
Bauer disc diffusion method on Mueller–Hinton Agar 
plates. Following antibiotics were used: amikacin (30 μg), 
gentamicin (10 μg), ciprofloxacin (30 μg), trimethoprim/
sulphamethoxazole (1.25/23.75 μg), tigecycline (15 μg) (Hi 
Media, Mumbai). MIC’s of various antibiotics were also 
determined on Mueller–Hinton Agar plates by agar dilu-
tion method according to CLSI and EUCAST guidelines 
[16, 17]. Following antibiotics were used: cefotaxime, cef-
tazidime, ceftriaxone, cefepime, imipenem, meropenem, 
ertapenem and aztreonam (Hi-Media, Mumbai, India).
Detection of DHA gene by polymerase chain reaction
Polymerase chain reaction (PCR) was performed target-
ing all the DHA genes by using a pair of primers as listed 
in Table 1. Isolates positive for DHA genes were further 
investigated for the presence of other AmpC gene fami-
lies, namely: CIT, ACC, FOX and EBC [18]. PCR ampli-
fication was performed using 30  µl of total reaction 
volume. Reactions were run under the following condi-
tions: initial denaturation at 95 °C for 2 min, 34 cycles of 
95 °C for 15 s, 51 °C for 1 min, 72 °C for 1 min and final 
extension at 72 °C for 7 min.
PCR products were purified by QIAquick Gel Extrac-
tion Kit (QIAGEN, Germany) and sequenced. Sequence 
results were analysed using a BLAST suite program of 
NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Molecular characterization of ESBL and carbapenemase 
genes by multiplex PCR
For amplification and characterization of ESBL genes, 
a set of five primers were used, namely: TEM, CTX-M, 
SHV, OXA-2, and PER [19]. Reactions were run under 
the following conditions: initial denaturation at 94 °C for 
5 min, 33 cycles of 94 °C for 35 s., 51 °C for 1 min, 72 °C 
for 1 min and a final extension at 72 °C for 7 min.
For amplification and characterization of carbapen-
emase genes, a set of seven primers were used, namely: 
KPC, IMI, NMC, SME, VIM, IMP, and NDM (Table 1). 
Reactions were run as described previously.
Transcriptional expression analysis of blaDHA‑1 
by quantitative realtime PCR
Expression of the blaDHA-1 gene was studied in response 
to cefoxitin, cefotaxime, ceftriaxone and ceftazidime 
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stress at different concentrations (2, 4, 8  µg/ml) and 
was determined by inoculating the organisms harbor-
ing blaDHA-1 in Luria–Bertani broth (Hi-media, Mum-
bai, India). Isolate without any antibiotic pressure was 
used as a control. A total RNA was isolated using Qia-
gen RNase Mini Kit (Qiagen, Germany), immediately 
reverse transcribed into cDNA by using QuantiTect® 
reverse transcription kit (Qiagen, Germany). The cDNA 
was quantified by Picodrop (Pico 200, Cambridge, UK) 
and quantitative real time PCR was performed using 
Power Sybr Green Master Mix (Applied Biosystem, War-
rington, UK) in step one plus real time detection system 
(Applied Biosystem, USA). The house keeping gene rpsel 
of E. coli was used as an internal standard [25]. DHA-1 
positive isolates showing resistance to broad spectrum 
cephalosporins and also devoid of other β-lactamases 
was selected for this study. The primer used for amplifi-
cation of DHA-1 is listed in Table 1. PCR reactions were 
performed in triplicates for the isolate. The reaction was 
run under the following conditions: 95  °C for 2 min, 32 
cycles of 95 °C for 20 s, 48 °C for 40 s and 72 °C for 1 min. 
The relative expression of blaDHA-1 at a different antibiot-
ics pressure was determined by the ΔΔCt method. Rela-
tive quantification was compared with strain grown for 
16 h without any antibiotic pressure.
Statistical analysis
The changes in DHA-1 mRNA expression in response to 
different β-lactam antibiotic stresses at different concen-
tration were analyzed using one-way ANOVA followed 
by Tukey–Kramer (Tukey’s W) multiple comparison test 
using SPSS version 17.0. Differences were considered sta-
tistically significant at both 5 and 1% level when p < 0.05. 
Data are presented as mean fold change + standard error 
of the mean.
Plasmid preparation
The bacterial isolates were cultured in Luria–Bertani 
broth (LB broth) containing 0.25  µg/ml of cefotaxime. 
Cultures were incubated on shaker incubator overnight 
at 37  °C, 160  rpm. Plasmids were purified by QIA prep 
Spin Miniprep Kit (QIAGEN, Germany).
Transferability of blaDHA gene by transformation 
and conjugation
The transformation experiments were carried out by heat 
shock method [26] using E. coli DH5α as the recipient. 
Transformants were selected on cefotaxime (0.5  µg/ml) 
containing LB Agar plates.
Conjugation experiments were carried out between 
clinical isolates as donors and a streptomycin resistant 
E. coli strain B (Genei, Bangalore) as the recipient. An 
overnight culture of the bacteria was diluted in Luria–
Bertani broth (Hi-Media, Mumbai, India) and was 
grown at 37  °C till the O.D. of the recipient and donor 
culture reached 0.8–0.9 at A600. Donor and recipient 
cells were mixed at 1:5 donor-to-recipient ratios and 
transconjugants were selected L.B Agar plates supple-
mented with cefotaxime (0.5  µg/ml) and streptomycin 
(600 µg/ml).
Plasmid incompatibiltiy typing
For detection of incompatibility group type of plasmid 
carrying blaDHA, PCR based replicon typing was carried 
out, targeting 18 different replicon types, to perform five 
multiplex and three simplex PCRs to amplify the FIA, 
Table 1 List of oligonucleotide primers for amplification of β‑lactamase genes
Serial no. Targets Primers pairs Sequence (5′→3′) Product size (bp) Reference
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FIB, FIC, HI1, HI2, I1-Ig, L/M, N, P, W, T, A/C, K, B/O, 
X, Y, F and FIIA replicons [27].
DNA fingerprinting by enterobacterial repetitive intergenic 
consensus sequences PCR
Typing of all blaDHA-1 producing E. coli isolates was done 
by enterobacterial repetitive intergenic consensus (ERIC) 
PCR as described previously [28]. Isolates were put into 
cluster based on banding pattern and dendogram was 
prepared by NTSYS software.
Results
During the study period, a total of 176 E. coli isolates 
were obtained from different clinical samples. Among 
these, 110 (62.5%) were resistant to cefoxitin and 63 
(35.8%) isolates were found to show AmpC activity by 
M3DET. By performing PCR, 16 isolates were detected 
for DHA genes and showed a sequence identical to that 
of DHA-1 (Table  1). These isolates harboring DHA-1 
gene were selected for further study. Among DHA-1 pos-
itive isolates four different ESBL genes were detected in 
10 isolates which include CTX-M (n = 6), SHV (n = 4), 
TEM (n = 3) and OXA-10 (n = 1). Carbapenemase gene 
(NDM-1) was detected only in one isolate. Other plasmid 
mediated AmpC β-lactamase CIT (n = 9), EBC (n = 2) 
were detected in nine isolates that carried either CTX-M 
(n = 3),SHV (n = 1), TEM (n = 1), NDM (n = 1) alone 
or CTX-M plus SHV(n = 2), CTX-M plus TEM (n = 1) 
and OXA-10 plus SHV (n = 1) (Table 2). These isolates 
harboring AmpC β-lactamase were mostly obtained from 
Surgery and medicine ward. To demonstrate whether 
DHA-1 expression would take place in the presence of 
different cephalosporins at a different concentration, an 
E.coli strain BM-567 (Table  2) harboring only DHA-1 
β-lactamase and showing resistance to broad spectrum 
cephalosporins was selected. The fold increase in mRNA 
production was measured using primer extension analy-
sis. It was observed that there was a significant increase 
in the expression of DHA-1 gene in response to cefo-
taxime, ceftriaxone, ceftazidime but not as high as those 
for cefoxitin when compared with the basal level without 
antibiotic pressure (Fig.  1). Though increased in tran-
scription was observed in response to these β-lactam 
antibiotics, high transcript level were achieved when 
induced by cefotaxime at 8 µg/ml (6.99 × 102 fold), cef-
triaxone at 2 µg/ml (2.63 × 103 fold), ceftazidime at 8 µg/
ml (7.06 × 103 fold) and cefoxitin at 4 µg/ml (3.60 × 104 
fold) (Fig.  1). The ANOVA and Tukey–Kramer (Tukey’s 
W) multiple comparison test for checking the differences 
in the expression of DHA-1 was found to be significant (p 
value is less than 0.05; Table 3).
Typing by ERIC-PCR confirmed 16 different haplo-
types (Fig. 2) indicating the diversity of the isolates. The 
susceptibility pattern of these blaDHA-1 harboring isolates 
showed resistance towards β-lactam including broad 
spectrum cephalosporin but most of them were suscepti-
ble against a carbapenem group of drugs. They also show 
susceptibility to tigecycline and moderate to high resist-
ance against amikacin, gentamycin, co-trimoxazole, cip-
rofloxacin. The MICs of selected β-lactam antibiotics for 
all the parental strains harboring DHA-1 were found to 
be above breakpoint level (Table 2). The transformation 
experiment could establish that DHA-1 was encoded in 
plasmid however, conjugation experiment revealed that 
only 4 isolates could conjugatively transfer DHA-1 gene 
in E. coli strain B which was confirmed by PCR analysis. 
On performing incompatibility typing it was established 
that most of the transformants with DHA-1 were asso-
ciated with K, FIA, L/M, FIB, HI1, B/O & I1 Inc group 
(Table 2).
Discussion
The first plasmid mediated AmpC β-lactamase, to be 
reported was CMY-1, in 1989 [29]. Since then, sev-
eral plasmid-encoded AmpC β-lactamases (ACC, FOX, 
MOX, CMY, ACT, etc.) have been reported in several 
genera of bacteria, including Salmonella spp., Pseu-
domonas spp., Proteus mirabilis and Klebsiella pneu-
moniae [7]. Among them plasmid encoded DHA-1; a 
clinically important AmpC β-lactamase was the first 
β-lactamase found to be inducible and can be expressed 
at higher levels in strains having AmpR regulatory gene 
[11, 30]. This plasmid- mediated β-lactamase is now 
being increasingly detected in a strain of E. coli world-
wide [31–33] and early detection of this β-lactamase 
(DHA-1) is mandatory for better antibiotic therapy and 
also to prevent further spread. The present study reports 
the prevalence of DHA-1 (9%) among E. coli strains in 
this region which is quite high compared to other studies 
[30, 32, 33] and typing of these DHA-1 harboring isolates 
by ERIC PCR revealed diverse haplotypes, indicating the 
spread of the DHA-1 gene through horizontal transfer. 
Based on the present susceptibility data (Table  2) and 
previous studies [11, 12], carbapenem and other non-
β-lactam antibiotics such as tigecycline could be better 
drugs of choice for the treatment of infections caused by 
E. coli producing DHA-1.
From the earlier study, it appears that E. coli lack one of 
the regulatory component (AmpR gene), which leads to the 
lower level, non-inducible expression of AmpC [34]. How-
ever, inducible cephalosporinase (blaCMY-13) found associ-
ated with an AmpR gene was detected recently in a strain 
of E. coli [35]. Several broad spectrum cephalosporins were 
believed to increase the expression of AmpC β-lactamase 
[36], although the concentration which leads to increase in 
the expression of AmpC β-lactamase was not established. 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Page 6 of 8Ingti et al. Ann Clin Microbiol Antimicrob  (2017) 16:13 
This study demonstrates higher transcription of DHA-1 
when induced with different cephalosporins. These dif-
ferences in the relative amounts of RNA transcription of 
DHA-1 gene, when induced with different cephalosporins 
at a concentration below MIC level suggest that the tran-
scription varies depending on the level of antibiotics stress. 
Higher AmpC production was supported by another find-
ing, where blaMIR-1, a plasmid-encoded AmpC gene 
exhibited a 95-fold increase in expression relative to WT 
AmpC [37]. Concentration dependent expression of AmpC 
cephalosporinase was also observed in a strain of Pseu-
domonas aeruginosa, when the strain was induced with 
cefoxitin or clavulanic acid at 8, 16 and 50  µg/ml [38]. 
So far, the factors behind the quantitative differences of 
AmpC expression in E.coli strain when exposed to differ-
ent β-lactam concentration is unknown. A transformation 
experiment could establish that all the DHA-1 gene were 
encoded in a plasmid which is in agreement with the pre-
vious study [12, 30–33] and Incompatibility typing from 
the transformants indicated that the plasmid encoding 
blaDHA-1 was carried mostly by FIA and L/M Inc group as 
found in another study [39]. Although detection of other 
Inc group, namely HI1, FIB, I1, K in the present study was 
mostly associated with CMY-2 and ACC harboring strains 
[39]. Plasmids carrying genes for AmpC β-lactamases 
often carry ESBL genes such as CTX-M [40, 41] as found 
in the present study, where most of these DHA-1 harbor-
ing isolates co-harbour ESBL genes (Table 2). Co-existence 
of New Delhi metallo-β-lactamase (NDM) gene was also 
observed in one isolate as the high prevalence of the E. coli 
harboring a metallo-β-lactamase known as the NDM has 





































Fig. 1 Transcriptional analysis of DHA-1 espression by RT-PCR. Total bacterial RNA was isolated from mid-log- phase cultures of E. coli. The error bars 
represent the standard deviations of the means of triplicate samples
Table 3 Statistical analysis of changes in DHA‑1 mRNA expression in response to different‑lactam antibiotic stress at dif‑
ferent concentration using one way ANOVA
NA no antibiotic; SEM standard error of the mean
* Significant (p < 0.05)
Sl no. β‑lactam antibiotics Value (Mean ± SEM) p value
NA 2 mg/l 4 mg/l 8 mg/l
1 Cefotaxime 1.00 ± 0 56.66 ± 1.18 58.10 ± 0.58 699.25 ± 5.27 0.001*
2 Ceftriaxone 1.00 ± 0 2634.69 ± 16.58 2383.97 ± 20.73 510.70 ± 6.04
3 Ceftazidime 1.00 ± 0 249.50 ± 11.63 356.27 ± 14.20 7059.48 ± 60.91
4 Cefoxitin 1.00 ± 0 17721.31 ± 608.47 35855.21 ± 1050.38 1363.69 ± 237.37
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Conclusion
Strains harboring plasmid mediated AmpC (DHA-
1) genes are often resistant to multiple antimicrobial 
agents and the overexpression of this resistant deter-
minant when induced with different cephalosporins 
stress will further limit treatment option. The present 
study demonstrates that higher expression of DHA-1 
takes place when induced with specific concentrations 
of β-lactam antibiotics, although further research is 
required to understand the factors behind the upregu-
lation of DHA-1 gene in the future. Therefore, revision 
in cephalosporin usage policy is required for effective 
treatment of patients infected with pathogen harboring 
this mechanism.
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